Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-09 Sale |
2023-06-09 7:55 pm |
FIBROGEN INC | FGEN | Brennan Aoife Director |
4,733 | $17.19 | $81,367 | 40,613 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:15 pm |
SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks |
19,042 | $0.5758 | $10,964 | 256,301 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-06 4:39 pm |
SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks |
8,894 | $2.4459 | $21,754 | 275,343 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-13 Option Award |
2025-01-15 4:15 pm |
N/A 2035-01-12 |
Climb Bio Inc. | CLYM | Brennan Aoife President and CEO |
1,150,000 | $0 | 1,150,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-06-27 7:05 pm |
N/A 2034-06-26 |
Eliem Therapeutics Inc. | ELYM | Brennan Aoife President and CEO |
825,000 | $0 | 825,000 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 4:10 pm |
N/A 2034-06-12 |
Xilio Therapeutics Inc. | XLO | Brennan Aoife Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-06 8:00 pm |
N/A 2034-06-04 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
70,000 | $0 | 70,000 (Direct) |
View |
| 2023-11-10 Option Award |
2023-11-14 7:23 pm |
N/A 2027-05-15 |
SYNLOGIC INC. | SYBX | Brennan Aoife President and CEO |
147,214 | $0 | 147,214 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 7:55 pm |
N/A 2033-06-06 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
20,955 | $0 | 40,613 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 9:08 pm |
N/A 2032-06-15 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
41,461 | $0 | 50,075 (Direct) |
View |
| 2022-02-04 Option Award |
2022-02-08 4:05 pm |
N/A 2032-02-04 |
SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks |
541,080 | $0 | 718,397 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 7:01 pm |
N/A 2031-05-25 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
12,500 | $0 | 16,414 (Direct) |
View |
| 2021-03-10 Option Award |
2021-03-12 4:50 pm |
N/A 2031-03-10 |
SYNLOGIC INC. | SYBX | Brennan Aoife See Remarks |
356,250 | $0 | 462,317 (Direct) |
View |
| 2020-08-05 Option Award |
2020-08-07 7:45 pm |
N/A 2030-08-05 |
FIBROGEN INC | FGEN | Brennan Aoife Director |
20,810 | $0 | 20,810 (Direct) |
View |
Ownership |
2020-08-07 7:25 pm |
N/A N/A |
FIBROGEN INC | FGEN | Brennan Aoife Director |
0 | $0 | 0 (Direct) |
View |